Animal industry officials hope the upcoming reauthorization of legislation guiding animal drug reviews will streamline the approval process, preventing the U.S. from falling behind foreign governments.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
